Medterra Is Reformulating Four Gummies and Pulling One on December 11

Affiliate disclosure: MyCannabisReviews may earn a commission when you buy through links on this page, including the Medterra links. That never changes what we publish, and every figure below was read on the brand’s own site on 22 October 2026 and is quoted as printed.

Medterra has published something most hemp brands have not: a dated, product-by-product account of what it is changing before the federal hemp deadline, and which of its products it believes are unaffected. Four of its gummies are being reformulated. One is being withdrawn outright on 11 December 2026. Its tinctures, capsules, topicals and pet products, it says, “remain compliant and available as usual.”

That last sentence is the one worth reading twice — not because it is obviously wrong, but because whether it holds depends entirely on a unit. Medterra describes the coming threshold in milligrams per serving. The statute, as we read it, is written in milligrams per container. On the first reading Medterra’s sorting of its own catalogue is coherent. On the second, the products it has placed in the safe column are the ones that would need the most work.

We cannot settle which reading governs, and we are not going to pretend otherwise. What we can do is put all four of Medterra’s own documents side by side, show the arithmetic in both units, and let you see exactly where the disagreement sits.

The Short Verdict

MCR Score: 8.8/10 — nothing on this page changes that score. Medterra has put a product-by-product account of the change in writing, with dates on it, and it has answered in writing whether it becomes illegal to keep what you already own. We rate both of those highly.

The open question is narrower and more technical: Medterra’s stated threshold is “currently anticipated around 3mg of total THC per serving.” Section 781 of P.L. 119-37, as we read it, sets a limit of 0.4 mg combined total per container — covering total THC plus other cannabinoids the FDA is required to list as having similar effects, a list the FDA has never published. Those are different units and different magnitudes. If the per-container reading is the operative one, moving a gummy from 5 mg to 2.5 mg does not bring a 20-count jar under it, and a full-spectrum tincture is not in the clear either.

If you buy Medterra gummies, the practical advice is simple and it is the advice Medterra itself gives: check the current lineup and do not assume the strength you buy today is the strength that ships in December.

What Medterra’s own pages say

We read four Medterra documents on 22 October 2026. They do not all say the same thing, and two of them do not link to each other.

1. The product-line update page

Medterra carries a dedicated page headed “Changes to Medterra’s product lineup starting December 11, 2026.” It prints no publication date, no revision date and no author, so we cannot tell you when it went up — only that it was live when we read it. It opens by explaining why:

“Redefining what qualifies as legal hemp has become a priority for the White House and Congress, and new federal legislation could narrow that definition in ways that affect some of our products.”

It then sorts the catalogue. One product goes: “Starting December 11, 2026, the following Medterra product will no longer be available” — Extra Delight 10mg THC Gummies. Four are being changed: “Daily Delight, Sound Asleep, Mood Boost, and Unwind are being actively reformulated to meet the new federal requirements.” And the rest, it says, are fine:

“No. Most Medterra products, including CBD tinctures, capsules, topicals, and pet products, remain compliant and available as usual.”

The page hedges carefully and repeatedly, and those hedges are Medterra’s own words, not ours: “Based on what we know today”, “This is the current plan based on what we know today, but things could still change”, and “could narrow that definition.” It also tells customers to act: “That’s why you have the chance to stock up on any of your favorites now, just in case”, and “This is the plan as of today, but it could still change, so stocking up early is the safest bet.”

Two of its answers are worth quoting in full. Asked whether possession becomes unlawful:

“No. This regulation affects which products Medterra can sell and ship. It doesn’t make it illegal for you to own or use products you’ve already purchased. Please check your state and local regulations for further information.”

And asked where a customer can read the rule themselves: “For more information on the federal hemp regulation, visit congress.gov or consult a legal professional familiar with hemp and cannabis law.” The page names no statute, no section and no public law — the only hemp law named anywhere on it is the 2018 Farm Bill, in the site’s standard shipping boilerplate. A reader sent to congress.gov without a bill number has a hard afternoon ahead of them, which is part of why we maintain a live tracker of the deadline itself.

2. The subscription blog post, dated 3 September 2026

Separately, Medterra has carried a post headed “What the New Federal Hemp Rules Mean for Your Medterra Subscription” since 3 September 2026 — one day after P.L. 119-103 was signed. It is bylined “Written by: Medterra News.” This is the document that carries the threshold figure, and here it is in full:

“The short version: starting December 11, 2026, hemp products sold in the U.S. are expected to fall under a new, lower THC threshold, currently anticipated around 3mg of total THC per serving.”

The sentence before it reads “Congress has been working through new federal rules that redefine how hemp-derived products, including CBD and THC gummies like ours, are regulated nationwide”, and the one after it reads “This is a nationwide change that affects the entire hemp industry, not a Medterra decision.” The post also tells subscribers what will happen to their orders: “your subscription will automatically move to our new 2.5mg formula”, and “Your subscription will automatically update to our new 2.5mg version starting with your first December shipment.” For the 10 mg line it says there is no equivalent: “There isn’t a direct 2.5mg-equivalent for the 10mg line, so your subscription won’t auto-convert the same way.”

Asked directly whether the company is closing, it answers: “No. We’re adjusting formulations to stay compliant with the new federal threshold.” On this page, ‘0.4’ and ‘per container’ are both absent, as are section 781, section 2019, P.L. 119-37 and P.L. 119-103. And the post does not link to the product-line update page — we found them separately.

3. The Extra Delight product page — which prints a countdown

The page for the product being withdrawn is the most direct of the four. It prints “Starting December 11, 2026, Extra Delight 10mg THC Gummies will no longer be available”, calls it “leaving in December”, says “Extra Delight won’t be back”, and carries “Stock up while you can” and “Shop now before it’s gone for good.” It links to the update page under the label “Federal hemp update.”

It also carries a live countdown. When we read it on 22 October 2026 it displayed “50 Days left to order.” Countdowns on brand sites are dynamic, so that figure only means anything with the date we read it attached — and from 22 October 2026, 50 days is 11 December 2026 exactly. Soul and Vena have both printed countdowns that resolved to the same date on the days we read them, and Soul has printed 11 December in words. Medterra’s timer is one more storefront arriving at the later of the two contested dates rather than the earlier one. One of its customer reviews has noticed too, writing that they “will be stocking up before the new law takes effect.”

4. The Max Relief oil page — which prints nothing about any of it

The fourth document is the one that makes the unit question concrete. Medterra’s Max Relief CBD + THC Oil sits in the tincture line that the update page says “remain compliant and available as usual.” Its product page prints no mention of December, no deadline, no ban, no reformulation and no new regulations — we checked each of those terms specifically. What it does print, in its own product imagery, is this: “Each 1500mg bottle contains True Full Spectrum CBD and 60mg of THC”, and “1500mg of CBD from organically grown hemp and 60mg of THC per bottle.”

Its ingredients panel prints 2 mg of THC and 50 mg of CBD, and its count selector prints “Single 30 Servings.” Two milligrams across thirty servings is sixty milligrams, which is our own arithmetic and which reproduces Medterra’s printed per-bottle figure exactly. On legality the page still uses the pre-2025 framing: “Although full spectrum CBD contains the federally legal amount of THC, no more than 0.3%”, and “Yes. According to the 2018 Farm Bill, hemp derived CBD products are legal in the United States as long as they don’t contain more than 0.3% THC.” The words “total THC” do not appear on it, and section 781 changed the test from delta-9 THC alone to total THC.

The products, the strengths and the prices

Every figure in this table was read on Medterra’s own site on 22 October 2026 and is quoted as printed. Where Medterra prints no pack count, we print none and we calculate nothing. Prices change and promotions rotate, so check the current figure before you buy.

One note on reading that table: Medterra printed no pack count for the four reformulating gummies on its update page, so there is no honest way for us to put a per-container figure against them, and we have not. The two products we can do arithmetic on are the two whose strength and count are printed on the same page on the same day.

The unit question, in both units

Here is the whole disagreement in one place. Medterra’s figure is per serving. The figure we take from section 781 is per container. The statutory definition of “container” is the innermost wrapping, packaging or vessel in direct contact with a final hemp-derived cannabinoid product — so a gummy jar is a container, and so is a tincture bottle.

Read the third column and Medterra’s decisions make complete sense. A 10 mg gummy is over three milligrams a serving, so it goes. A 5 mg gummy is over, so it is reformulated to 2.5 mg, which is under. A tincture at 2 mg a serving is already under, so nothing needs to happen to it. Medterra’s sorting of its own catalogue is internally consistent with the number Medterra published. This is not a brand being careless.

Now read the fifth column. The same tincture that is comfortably under on a per-serving basis carries sixty milligrams of THC in the bottle, on Medterra’s own printed figure, which is 150 times the 0.4 mg per-container figure. The withdrawn gummy is 500 times it. On this reading the gummies are not the hard part of the catalogue; the tinctures, capsules and topicals are, and those are the products the update page lists as unaffected.

We are not the only people who have noticed that the per-container figure reaches ordinary CBD products. Jonathan Miller, general counsel of the U.S. Hemp Roundtable, a hemp industry trade association, put it this way to Harvest Public Media: “Even the vast majority of non-intoxicating CBD products have more than 0.4 milligrams of THC per container.” That is a lawyer for the industry describing the same category Medterra has placed in the safe column.

What this does and does not tell you

We think the distinction above is the single most useful thing a shopper can understand about December, so we want to be exact about its limits.

• 0.4 mg per container is our reading of the statute, not a settled fact. The FDA has never published the lists of cannabinoids section 781 requires it to publish — they were due 10 February 2026 and are 254 days late as of 22 October 2026. The restrictions take effect regardless; the missing lists determine only how far past total THC the exclusions reach.
• 11 December is also our reading, and it is a minority reading. Section 2019 of P.L. 119-103 carves two subclauses out of the delay rather than moving the date, and several well-regarded law firms read the operative date as 12 November 2026 — 21 days from 22 October 2026, against 50 for 11 December. We think our reading is right and we have set out why in our guide to which cannabinoids lose hemp status, but if you are planning a purchase, plan for November and treat December as upside.
• Medterra’s figure may be describing something we are not. Its page says “expected to” and “currently anticipated”, and it names no statute. It may be describing a proposal, a draft, an industry expectation, or guidance we have not seen. We asked the page what law it was describing and it answered with congress.gov.
• We have not reconciled the two figures and we are not going to guess. Two numbers in two units from two kinds of source is a question, not an error. If you are a Medterra subscriber, the useful move is to ask Medterra directly whether its threshold is per serving or per container — its page lists support@medterracbd.com — because the answer changes what happens to your tinctures, not just your gummies.
• Our arithmetic is arithmetic, not a legal conclusion. Multiplying a printed per-serving figure by a printed count tells you what is in the jar. Whether that jar is lawful on a given date is a question for a lawyer and for a final rule that does not yet exist.

Our Three Picks

These are the three we would actually buy right now, chosen for what the next few weeks look like rather than for price alone. A brand score is not a product score, and none of these is a recommendation to stockpile.

1. Best for knowing where you stand: Medterra Max Relief CBD + THC Oil — $89.99 one-time, $67.49 on “Subscribe & Save 25%”, read 22 October 2026. We are recommending it with the caveat above attached: it is the product whose status depends most on the unit question. We rank it because Medterra prints its THC content in two places and its count in a third, so a buyer who understands the per-container question has the figures needed to make their own decision. Read our full Medterra review first.
2. Best lab paperwork: CBDfx tinctures — CBDfx publishes per-strength, per-batch certificates with batch numbers and dates and an archive running back to 2020, which is the best lab disclosure of any brand we carry. The caveat we always print: the most recent certificate we found on one of its calming products was dated September 2025, so check the date on the batch you are buying.
3. Most explicit about the date: Soul Out of Office — when we read Soul’s product pages in September it printed the calendar date in words, including “Ships until December 11, 2026” and “The federal THC ban takes effect December 11. We cannot ship after that and there is no reorder.” “THC ban” is Soul’s phrase and not a statutory term, and Soul has scoped that statement to its own Out of Office line and to shipping. But if you want a brand that is not leaving you to infer the date, this is it.

Lab testing: what to check before December

If a brand is reformulating, the batch in front of you and the batch on its certificate may not be the same product. That makes the certificate date the most important number on the page, and it is the one shoppers skip.

Three things to check, in order. First, that the certificate names total THC and not only delta-9 THC — section 781 changed the test, and a certificate reporting delta-9 alone no longer answers the question. Second, that the batch number on the certificate matches the batch on the jar. Third, that the certificate is recent enough to describe the formula you are buying, which matters more than usual while four Medterra products are mid-reformulation. Our guide to reading a COA walks through each of those with examples, and CBDfx’s published lab reports are a reasonable model of what good disclosure looks like.

For completeness on the brand we are writing about, as recorded at our last review: Medterra claims ISO 17025 accreditation and offers batch lookup by QR code, it does not test for herbicides or glyphosate and discloses that openly, and it does not name its laboratory. That is a middling-to-good disclosure record, and it is part of why it scores 8.8 rather than higher.

Buy if, look elsewhere if

Buy Medterra if you want a brand that will tell you in writing what is changing and when, you are buying gummies and are comfortable that the strength may change in December, or you are a subscriber who would rather be moved automatically to a 2.5 mg formula than have an order fail. The fact that it has put the possession answer in writing at all is worth something. Check the current Medterra lineup.

Look elsewhere if you specifically want a 10 mg per-gummy product to keep existing past December, because Medterra has said that one is going and that there is no direct equivalent in its range. If that is what you are after, CBDfx’s gummy range is the alternative we would point you at, with the same warning attached: the per-container question applies to every brand equally, and we have not seen a per-container THC figure printed on any gummy jar we have read. Our best CBD gummies ranking and best delta-9 gummies ranking both compare the alternatives on price per milligram.

Where the deadline itself stands

Medterra’s page points customers at congress.gov without a bill number, so here is the short version of what it is pointing at. Section 781 of P.L. 119-37 rewrote the statutory definition of hemp, changing the limit to a total THC concentration of less than 0.3% on a dry weight basis and adding the per-container limits. Section 2019 of P.L. 119-103, signed 2 September 2026, then carved two subclauses out of that change until 11 December 2026 — which is why the date is contested, and why we read it as 11 December while others read 12 November.

Nothing has been settled since. The Senate declined to remove the provision when it was asked to by name, tabling an amendment whose stated purpose was “To strike section 2019” by 61 votes to 32 at 2:36 in the morning on 8 August — a procedural vote, which means the Senate declined to remove the provision when asked, not that 61 senators endorsed the delay on its merits. A bipartisan bill that its sponsor’s office describes as establishing a regulatory framework for hemp-derived products through the FDA has sat in committee since January. We keep all of it current in one place:

• The Federal Hemp THC Deadline: A Live Tracker — dates, bills and state positions as they move.
• Which cannabinoids lose hemp status, and when — the subclause reasoning behind our 11 December reading.
• What CBD brands are telling customers about 11 December — how the storefronts we buy from are handling it.
• The HEMP Act, H.R. 7212 — the FDA-regulation bill parked in Energy and Commerce.
• The 61-32 vote on striking section 2019 — what the Senate actually voted on.

For the wider picture of which brands we rank and why, our guide to the best CBD and hemp brands of 2026 compares all of them on score, price anchor and use case, and how we review explains what the MCR Score does and does not measure.

Frequently asked questions

Is Medterra going out of business?

No, and Medterra has answered this itself: “No. We’re adjusting formulations to stay compliant with the new federal threshold.” Its update page also says most of its catalogue is unaffected.

Which Medterra products are changing?

On its own account, one is being withdrawn and four are being reformulated. Extra Delight 10mg THC Gummies “will no longer be available” from 11 December 2026. Daily Delight, Sound Asleep, Mood Boost and Unwind are, in Medterra’s words, “being actively reformulated to meet the new federal requirements.” Medterra describes its tinctures, capsules, topicals and pet products as unaffected.

What will the reformulated gummies be?

Medterra’s subscription post says subscribers on the 5 mg gummies will move to “our new 2.5mg formula”, automatically, starting with the first December shipment. It says there is no direct 2.5 mg equivalent for the 10 mg line.

Does it become illegal to own what I already bought?

Medterra’s answer, quoted in full: “No. This regulation affects which products Medterra can sell and ship. It doesn’t make it illegal for you to own or use products you’ve already purchased. Please check your state and local regulations for further information.” We would add the same caveat Medterra does: state law is separate and some states are moving on their own timetables. The Illinois Department of Agriculture, for example, has published that “On November 12, 2026, the Industrial Hemp Act will be repealed”, regardless of how the federal date resolves.

Is the new limit 3 mg per serving?

That is the figure Medterra publishes, hedged as “expected to” and “currently anticipated around 3mg of total THC per serving.” It is not the figure we take from the statute. We read section 781 as setting 0.4 mg combined total per container, which is a different unit and a much smaller number. We have not reconciled the two and we publish both.

Should I stock up?

Medterra says “stocking up early is the safest bet” and that is its view of its own inventory, which it is better placed to judge than we are. Ours is narrower: do not buy more than you would normally use, and if you do buy ahead, check the brand’s own returns window first — Medterra’s page prints a 30-day refund period from receipt, which is shorter than the gap to December.

Does any of this affect CBD products with no THC?

On a per-serving reading, no. On a per-container reading it is the open question, because full-spectrum products contain THC by design and the industry’s own general counsel has said most non-intoxicating CBD products exceed 0.4 mg per container. A true isolate product is a different case. This is the part of the rule we would most like the FDA’s missing lists to clarify.

The bottom line

Medterra deserves credit for publishing a product-by-product account with dates on it, and for answering the possession question in plain words. Its sorting of its own catalogue is coherent on the number it published.

But the number it published is per serving, and the number we read in the statute is per container, and the gap between those two units is the difference between a gummy problem and a whole-catalogue problem. A 2 mg-per-serving tincture is under three milligrams and carries sixty milligrams in the bottle. Both of those are true at once. Which one matters on 11 December is the question we cannot answer for you — but it is the question to ask before you buy, and it is the question to put to any brand that tells you its products are unaffected.

Check Medterra’s current lineup or see how Soul is handling the same deadline, and keep the live tracker bookmarked — we update it as the date moves.

Affiliate disclosure: MyCannabisReviews may earn a commission when you buy through links on this page, including the Medterra links. Prices, strengths, counts and countdown figures were read on the brands’ own sites on 22 October 2026 and are quoted as printed; they change without notice. Nothing here is legal advice. Our reading of the statute is our reading, and we have marked it as such wherever it appears.